During the past decade, Tekton Research, Inc. conducted 93 clinical trials. In the 10-year time frame, 93 clinical trials started and 46 clinical trials were completed, i.e. on average, 49.5% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 34 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tekton Research, Inc." #1 sponsor was "Pfizer" with 23 trials, followed by "ModernaTX, Inc." with 13 trials sponsored, "Allergan" with 6 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "Genocea Biosciences, Inc." with 6 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tekton Research, Inc." #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator and "Database Integrations, Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Tekton Research, Inc." are "Systemic Lupus Erythematosus" (7 trials), "COVID-19" (6 trials), "Migraine, With or Without Aura" (6 trials), "Rheumatoid Arthritis" (6 trials) and "SARS-CoV-2 Infection" (6 trials). Many other conditions were trialed in "Tekton Research, Inc." in a lesser frequency.

Most popular intervention types in "Tekton Research, Inc." are "Drug" (55 trials), "Biological" (53 trials), "Other" (10 trials), "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "mRNA-1273" (5 trials), "Atogepant" (4 trials), "Rimegepant" (4 trials) and "mRNA-1647" (4 trials). Other intervention names were less common.

The vast majority of trials in "Tekton Research, Inc." are 100 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Tekton Research, Inc.". undefined are not yet recruiting, 15 are recruiting, 19 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 56 completed trials in Tekton Research, Inc., undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Tekton Research, Inc., 7 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".